Lowers the risk of MI,revascularization, andcardiovascularmortalityin…. ANDA 76714, held by Dr Reddys Labs Inc. Pravastatin Sodium.
As of Nov 16, 2026, ANDA 76714 (Pravastatin Sodium), held by Dr Reddys Labs Inc, was first approved by FDA on Oct 23, 2006, with 7 approved supplements and 0 published complete response letters.
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. Pravastatin sodium is an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce the risk of MI,revascularization, andcardiovascularmortalityin hypercholesterolemicpatientswithout clinicallyevidentCHD.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 23, 2006 | Original application | Approved | None posted |
| Pravastatin Sodium10MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium20MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium40MG · tablet;oral | Pravastatin Sodium | Rx |
| Pravastatin Sodium80MG · tablet;oral | Pravastatin Sodium | Rx |
| Jun 26, 2025 | Supplement 14Labeling · Standard review | Approved | None posted |
| Nov 25, 2016 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 1, 2016 | Supplement 8Labeling · Standard review | Approved | None posted |
| Nov 3, 2014 | Supplement 7Labeling · Standard review | Approved | None posted |
| Jul 20, 2012 | Supplement 6Labeling | Approved | None posted |
| Dec 28, 2007 | Supplement 1Labeling | Approved | None posted |
| Dec 28, 2007 | Supplement 2Manufacturing | Approved | None posted |
| Oct 23, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters